iRhythm Technologies, Inc. (IRTC) vs Parabilis Medicines, Inc. (PBLS)
A side-by-side comparison of iRhythm Technologies, Inc. and Parabilis Medicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IRTC
iRhythm Technologies, Inc.
$107.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PBLS
Parabilis Medicines, Inc.
$28.86HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IRTC vs PBLS
growth of $100 · dividends reinvested · last 1yIRTC +0.9% (+0.9%/yr)PBLS +47.7% (+47.7%/yr)PBLS compounded faster over this window
IRTC PBLS
IRTC vs PBLS: by the numbers
- •IRTC is the larger company ($3.52B vs $3.36B market cap).
- •Both run net losses; PBLS's is the smaller (0.00% vs -1.69% net margin).
Metrics side by side
Valuation
| Metric | IRTC | PBLS |
|---|---|---|
| P/S ratio | 4.27 | N/A |
| P/B ratio | 18.94 | 3.21 |
| EV / EBITDA | 286.35 | N/A |
| FCF yield | 1.11% | N/A |
Profitability
| Metric | IRTC | PBLS |
|---|---|---|
| Gross margin | 71.45% | 0.00% |
| Operating margin | -1.17% | 0.00% |
| Net margin | -1.69% | 0.00% |
| ROE | -7.50% | N/A |
| ROIC | -1.07% | -409.85% |
Growth (annualized)
| Metric | IRTC | PBLS |
|---|---|---|
| Revenue CAGR (5Y) | 21.93% | N/A |
| Total return CAGR (5Y) | 12.95% | N/A |
Go deeper
Dig into the metrics
iRhythm Technologies ROEParabilis Medicines ROEiRhythm Technologies operating marginParabilis Medicines operating marginiRhythm Technologies revenue growthParabilis Medicines revenue growthiRhythm Technologies free cash flowParabilis Medicines free cash flow
iRhythm Technologies & Parabilis Medicines appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.